Literature DB >> 21963692

The overlap of cognitive impairment in depression and schizophrenia: a comparative study.

Mojca Soštarič1, Bojan Zalar.   

Abstract

BACKGROUND: Schizophrenia (SCH) is primarily a cognitive dysfunction. Its specific cognitive impairment profile was identified and suggestions have been made to include it in present diagnostic instruments as a special differential diagnostic criterion. However, studies indicate a substantial overlap of cognitive deficits between SCH patients and those with depression (DEP). In order to elucidate the structure of cognitive functioning in both entities, principal cognitive domains of SCH and DEP patients were assessed in the acute phase of disease. SUBJECTS AND METHODS: 44 SCH and 30 DEP patients, matched according to age, gender, education, IQ score, and duration of hospitalization were included. Neurocognitive assessments were performed in the first week of hospitalization using Digit Span test (working memory, attention), Trail Making Test (psychomotor speed, sustained attention, shifting), Rey's Complex Figure Test and Verbal Learning Test (perceptual organization, visual and verbal learning and memory). Results were evaluated according to demographically matched test norms. For statistics Student's t tests were used.
RESULTS: In both study groups deficits in maintenance and shifting of attention during psychomotor tasks were found, while automatic processes (working memory, sustained attention) were preserved. In both groups memory and learning processes were impaired, in DEP however, deficits in attention shifting during cognitive tasks and delayed recall of visual material were more intense.
CONCLUSIONS: In the acute phase of schizophrenia and depression similar cognitive impairment profiles can be found. Further studies are needed to assess longitudinal dynamics and possible later development of specific patterns of cognitive functioning in these patients.

Entities:  

Mesh:

Year:  2011        PMID: 21963692

Source DB:  PubMed          Journal:  Psychiatr Danub        ISSN: 0353-5053            Impact factor:   1.063


  6 in total

1.  Psychiatric symptom versus neurocognitive correlates of diminished expressivity in schizophrenia and mood disorders.

Authors:  Alex S Cohen; Yunjung Kim; Gina M Najolia
Journal:  Schizophr Res       Date:  2013-03-06       Impact factor: 4.939

Review 2.  Neurocognitive deficits in depression: a systematic review of cognitive impairment in the acute and remitted state.

Authors:  Dominik Kriesche; Christian F J Woll; Nadja Tschentscher; Rolf R Engel; Susanne Karch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-09-01       Impact factor: 5.760

3.  Depression Predicts Global Functional Outcomes in Individuals at Clinical High Risk for Psychosis.

Authors:  Wisteria Deng; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Scott W Woods; Elaine F Walker; Jutta Joormann; Tyrone Cannon
Journal:  Psychiatr Res Clin Pract       Date:  2021-11-17

4.  Neural correlates of the preserved inhibition of return in schizophrenia.

Authors:  Yingying Tang; Yan Li; Kaiming Zhuo; Yan Wang; Liwei Liao; Zhenhua Song; Hui Li; Xiaoduo Fan; Donald C Goff; Jijun Wang; Yifeng Xu; Dengtang Liu
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

5.  Low prevalence of lipid metabolism abnormalities in APOE ε2-genotype and male patients 60 years or older with schizophrenia.

Authors:  Chunxia Ban; Qunying Zhang; Jie Feng; Huijuan Li; Qi Qiu; Yuan Tian; Xia Li
Journal:  BMC Psychiatry       Date:  2017-12-12       Impact factor: 3.630

6.  Differential aberrant connectivity of precuneus and anterior insula may underpin the diagnosis of schizophrenia and mood disorders.

Authors:  Katrin Aryutova; Rositsa Paunova; Sevdalina Kandilarova; Kristina Stoyanova; Michael Hj Maes; Drozdstoy Stoyanov
Journal:  World J Psychiatry       Date:  2021-12-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.